Skip to main content

Wegovy Pill Cost: Current Dose-Specific Offers

By the Peptide Dossier Editorial TeamUpdated How we source

The Wegovy pill’s $149 offer applies to the 1.5 mg starting strength, not every dose or a full course. Compare the prescribed formulation, current dose-specific offer and complete care bill. A tablet and an injection are not automatically interchangeable because both contain semaglutide.

Current pill and pen prices

The current manufacturer display lists tablets at $149 for 1.5 mg, $199 for 4 mg and $299 for 9 or 25 mg per 30-tablet bottle. Injection self-pay offers list $349 per four-pen, 28-day supply for 0.25–2.4 mg or $399 for HD 7.2 mg. Eligible new injection-offer patients can instead pay $199 for each of the first two 0.25/0.5 mg fills completed by December 31, 2026; eligibility requires no Wegovy injection savings redemption in the preceding 365 days. A third fill uses standard pricing.

The self-pay terms prohibit seeking reimbursement or applying the expense toward insurance deductibles or out-of-pocket requirements. These medicine-only offers are conditional, may change and do not include every clinician, membership, lab or delivery charge.

Insurance and commercial savings

The commercial offer is as little as $25 for eligible patients with coverage for the prescribed presentation, subject to maximum savings of $100 per monthly supply, $200 for two or $300 for three. A higher covered cost share can leave more than $25 to pay. Pen and tablet supplies mean 28 and 30 days respectively.

Government prescription beneficiaries are excluded from this commercial offer. FEHB, marketplace and state-employee plans are treated as commercial under these terms. Accumulator/maximizer arrangements make the offer ineligible. A valid prescription for an approved labeled indication and eligibility at every fill are required. Other discounts generally cannot be combined, apart from the permitted manufacturer automatic eVoucher.

Ask the plan specifically about Wegovy tablets and the treated indication. Coverage of an injection does not establish tablet coverage, and the formulations do not have identical indication lists. Eligible Medicare Bridge access is separate from ordinary Part D coverage. Medicaid rules depend on the actual state and plan.

Assistance and other prices

The official PAP product list does not list Wegovy. Do not promise free Wegovy from another product’s income rules or application process. An independent discount card is a separate pharmacy quote; no fixed percentage saving or universal best price was verified.

Compare actual pharmacy or manufacturer quotes for other medicines rather than a pill starting offer against another brand’s list price. Foundayo is now an approved oral option with its own label and offers; it is no longer merely a future launch assumption. No universal cheapest-brand ranking or generic-price forecast is established here.

Positive oral trial evidence and its limits

OASIS 4 randomized 307 adults with obesity or overweight and a related condition, without diabetes, to oral semaglutide 25 mg or placebo with lifestyle intervention. The published abstract reports mean weight change at 64 weeks of −13.6% versus −2.2%; the trial-product analysis assuming continued treatment reported −16.6% versus −2.7%. Original trial abstract. These positive findings do not establish equivalence to injectable Wegovy in a direct randomized comparison or a guaranteed individual result.

Administration, suitability and switching

The current label specifies once-daily tablets with morning empty-stomach and water/waiting instructions, while injections are weekly. The actual prescribed label should govern use. Do not change formulations, select a lower maintenance dose to lower cost or extrapolate injection storage and dosing to tablets. The clinician should assess suitability and manage any transition.

Budget for the treatment actually prescribed

Ask for the first-fill and ongoing medicine amounts plus clinician access, required membership, testing and supplies. A starting price times twelve is not an annual treatment quote. Pharmacy stock, insurer approval, support quality and delivery speed were not tested here.

Related reading

Wegovy Cost Guide

Full pricing guide for injectable Wegovy including insurance and savings options.

Oral Wegovy Guide

Complete guide to the oral Wegovy pill — how it works, side effects, and clinical data.

Semaglutide Cost Without Insurance

Compare all semaglutide pricing options for patients paying out of pocket.

Wegovy Pill vs. Injection

Side-by-side comparison of oral and injectable Wegovy formulations.

Frequently Asked Questions

Current manufacturer self-pay prices are $149 for 1.5 mg, $199 for 4 mg and $299 for 9 or 25 mg per 30-tablet bottle, subject to terms. Clinical and membership fees may be separate.

The actual covered amount is plan-specific. Eligible commercial savings advertise as little as $25 with maximum savings of $100 per monthly supply; this does not guarantee a $25 bill.

Compare actual applicable tablet and pen offers for the prescribed dose and period. A tablet entry offer versus an injection list price does not establish a universal saving.

Ask the plan about the exact tablet, indication, authorization and renewal. Existing injection coverage does not automatically establish tablet coverage.

Current terms include tablet commercial savings and separate self-pay offers. The official PAP product list does not list Wegovy; free-drug assistance should not be assumed.

Use current offers for the actual products, not another brand’s list price. Ozempic has distinct formulations, indications and terms; no universal cheapest comparison is established.

The oral placebo-controlled trial showed positive weight loss, but it was not a randomized comparison with injection. Trial population, dose, duration and analysis affect the estimates.

Discuss the actual formulation, instructions, clinical suitability and complete cost with the prescriber. Do not infer a switching dose or guarantee a saving from the starting price.

Disclaimer: This guide is for informational purposes only and does not constitute medical or financial advice. Medication prices are estimates based on publicly available information and may vary by pharmacy, location, and insurance plan. Prices are subject to change. Consult with your healthcare provider and insurance company for exact pricing and coverage. Always obtain prescriptions through licensed healthcare providers.